HRT Financial’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.42M Buy
+230,777
New +$6.6M 0.01% 1227
2024
Q1
– Sell
-2,543
Closed -$25K – 2290
2023
Q4
$25K Buy
+2,543
New +$24.2K ﹤0.01% 2017
2022
Q3
– Sell
-1,753
Closed -$44K – 2773
2022
Q2
$44K Sell
1,753
-681
-28% -$15.7K ﹤0.01% 2521
2022
Q1
$60K Buy
+2,434
New +$52.3K ﹤0.01% 2726
2021
Q3
– Sell
-7,242
Closed -$337K – 3253
2021
Q2
$337K Buy
7,242
+4,619
+176% +$229K ﹤0.01% 2073
2021
Q1
$144K Buy
2,623
+228
+10% +$15.1K ﹤0.01% 2392
2020
Q4
$173K Buy
+2,395
New +$281K ﹤0.01% 1526

Other funds holding ASMB

HRT Financial's ASMB Position: Q3 2026 in Review

HRT Financial opened a new position in Assembly Biosciences (ASMB) in Q3 2026: 230,777 shares worth $5.42M. The stake represents 0.01% of the portfolio and ranks #1227 among its holdings. This is a return to the name: HRT Financial previously reported a position in ASMB as recently as Q4 2023.

HRT Financial first reported a position in ASMB in Q4 2020 and has held it in 7 quarters since. 54 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.

  • HRT Financial held 230,777 shares of Assembly Biosciences worth $5.42M as of Q3 2026.
  • Assembly Biosciences was a new HRT Financial position in Q3 2026.
  • Assembly Biosciences made up 0.01% of HRT Financial's portfolio in Q3 2026, its #1227 holding.
  • HRT Financial first reported a position in Assembly Biosciences in Q4 2020 and has held it in 7 quarters since.
  • 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.